Be-Sheng Kuo

Corporate Officer/Principal chez AbGenomics International, Inc.

Health Technology

Consumer Services

Postes actifs de Be-Sheng Kuo

Sociétés	Poste	Début	Fin
AbGenomics International, Inc. AbGenomics International, Inc. Pharmaceuticals: MajorHealth Technology AbGenomics International, Inc. manufactures biopharmaceutical therapeutics. The firm produces therapeutics for the treatment of cancer and immune related inflammatory diseases. It also performs research discovery, preclinical and clinical development, as well as strategic planning for commercialization of its therapeutics. The company was founded by Rong-Hwa Lin in 2000 and is headquartered in Los Altos, CA.	Corporate Officer/Principal	-	-

Sociétés	Poste	Début	Fin
IDEC Pharmaceuticals Corp. IDEC Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology IDEC Pharmaceuticals Corp. used to develop and commercialize targeted immunotherapies for the treatment of cancer and autoimmune diseases. The company’s products used to act chiefly through immune system mechanisms, exerting their effect by binding to specific, readily targeted immune cells in the patient’s blood or lymphatic system. The company was headquartered in San Diego, CA.	Directeur Technique/Scientifique/R&D	01/01/1999	01/01/2003
Parke-Davis Pharmaceutical Research, Inc.	Directeur Technique/Scientifique/R&D	01/01/1993	01/01/1999
Marion Merrell Dow, Inc.	Directeur Technique/Scientifique/R&D	01/01/1988	01/01/1993

University of Cincinnati (Ohio)

Doctorate Degree

Internationale

Etats-Unis

Opérationnelle

Chief Tech/Sci/R&D Officer	3
Corporate Officer/Principal	1
Doctorate Degree	1

Sectorielle

Health Technology	4
Consumer Services	2

Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Entreprise privées	4
AbGenomics International, Inc. AbGenomics International, Inc. Pharmaceuticals: MajorHealth Technology AbGenomics International, Inc. manufactures biopharmaceutical therapeutics. The firm produces therapeutics for the treatment of cancer and immune related inflammatory diseases. It also performs research discovery, preclinical and clinical development, as well as strategic planning for commercialization of its therapeutics. The company was founded by Rong-Hwa Lin in 2000 and is headquartered in Los Altos, CA.	Health Technology
IDEC Pharmaceuticals Corp. IDEC Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology IDEC Pharmaceuticals Corp. used to develop and commercialize targeted immunotherapies for the treatment of cancer and autoimmune diseases. The company’s products used to act chiefly through immune system mechanisms, exerting their effect by binding to specific, readily targeted immune cells in the patient’s blood or lymphatic system. The company was headquartered in San Diego, CA.	Health Technology
Parke-Davis Pharmaceutical Research, Inc.
Marion Merrell Dow, Inc.	Health Technology